Extract from the Register of European Patents

EP Citations: EP1820509

Cited inSearch
Type:Patent literature
Publication No.:US4479938  [DY]
 (THOMAS WILLIAM R [US]) [DY] 1-5 * claims 1-7 * * example 1 *;
Type:Patent literature
Publication No.:EP0346241  [DY]
 (FOND NAT TRANSFUSION SANGUINE [FR]) [DY] 1-5 * claims 13-15 * * examples 1-3 *;
Type:Patent literature
Publication No.:US5344918  [A]
 (DAZEY BERNARD [FR], et al) [A] 1-17 * claims 1,2 * * column 4, lines 63-68 *;
Type:Patent literature
Publication No.:US5891843  [XY]
 (TURECEK PETER [AT], et al) [XY] 1-5 * abstract;; examples 1-8 * * column 4, lines 32-36 *;
Type:Patent literature
Publication No.:US2002115590  [X]
 (JOHANNESSEN MARIE [DK], et al) [X] 1-5 * claims 1,2 * * paragraphs [0028] , [0052] , [0054] *;
Type:Non-patent literature
Publication information:[DX]  - TOMOKIYO K ET AL, "Large-scale production and properties of human plasma-derived activated Factor VII concentrate", VOX SANGUINIS, S. KARGER AG, BASEL, CH, (200301), vol. 84, no. 1, ISSN 0042-9007, pages 54 - 64, XP002286502 [DX] 1-5 * abstract *
DOI: http://dx.doi.org/10.1046/j.1423-0410.2003.00247.x
Type:Non-patent literature
Publication information:[X]  - HEDNER U ET AL, "CLINICAL EXPERIENCE WITH HUMAN PLASMA-DERIVED FACTOR VIIA IN PATIENTS WITH HEMOPHILIA A AND HIGH TITER INHIBITORS", HAEMOSTASIS, BASEL, CH, (1989), vol. 19, no. 6, pages 335 - 343, XP009058664 [X] 1-5 * abstract * * page 336, column 2, paragraph 2 - page 337, column 1, paragraph 2 *
Type:Non-patent literature
Publication information:[A]  - BJOERN AND L THIM S ET AL, "Activation of coagulation factor VII to VIIa (S Bjoern and L Thim, Novo Research Institute)", RESEARCH DISCLOSURE, MASON PUBLICATIONS, HAMPSHIRE, GB, (198609), vol. 269, no. 60, ISSN 0374-4353, XP007110994 [A] 1-17 * whole document *